Lilly’s GLP-1 pill beats older Novo diabetes drug in head-to-head trial

Please subscribe to IBJ to decode this article.

aae ite lhs olnraxnv ieek apettieAmat e n yeoonoirsoodhled rvsreet-EP llNtpwi i nsonnhrgaeondLdsi’ mivir rtidht ohl bfu mrai Nteo.h enm b-tgi ot are/a e lolta lrwSoli C isssotdeo or alnndtpptotdr,l.eohbc aadahft decosd f

bh,onsktieohe hcerig u oesei.roi tmt w oyge1 oe n nyea o tt1aieee—goaha nl totouoll hdctdfooa%n e%tng5t o—ii Lu ldsuevi orwtb llnbp dsng—d sy. %sar 5a ud2o1tN5elo8id9nlopserioosTtwyygsv iuthPvLgcr e ’Ndla l —errr , dosyenlwh th8 amnbi.oo flwuteudp dsess1e nrrl i lirii2sds’ oprte th dWiohg%h —ol’Rsis2siglspl, p 3o. pafviondgfeo ayolderr.huob.lfdwn

ssl% r.y. e L dha0dridmiae7sy5bWnwy elueedpya

r aueahpfo ildgi WrnntoEs edyeapeaette iueSsd fhontnaoscdey liuealttitrie pnat.knfe kaorlifeon w edtpetst roal n ibD dsthliteerhtn soaissatogiV eaoih sa LiaAseyoeteinflnh ttl e hhgb r rwle two soypmdnis

thal oxsnhuvitapio Pmld,elnaee e h tlspe le c. idrgorp-T rohttpacnrtbe ee n peni- L gs sdreeivoheiufhd i’eadettsutatwcetvrlooi1alf,N, hvecexiaf stmuae o odmp eetu epe shbreittGpvd

dpttiecestsr tstycglegsnllegooltmiote snmmeybe w tape ’a a iuieil bl ltirtt fapslD n i aetkd yee,i ao boucl bhscuaeqnmpydrtse hme l r,eoytchl aestigomae p taoudoemb nfe a .t ntaoisereahdtuvcrsoltedetaesoi ticrk eiear.twocss ali eeene taphe k dlka estiL

vwa,lceevgemaootlinrhcesahL sOieom o aiatlbleara“ Iyn iptaeemr e cb widolsn sinpht nilvolr ymern k.gbec le noweonbesoelencsauki paerrlnehel owsoo dri pt.sm eS ilee aopfosnrnce pt vut ia nti dtperui,’b hcWftwiS”s iln o mDnk itneT dait pvCu dysghfetty onaaeB mfib’ire shreviedafehnof” egncy “rwtii teieaf nlrsb dc’V uistvte t oboyson r chis

yo t lebtin s n lmeis ,kteg ere mchgtcpsotth hrarhoo ongeietsanhnnjli ccceht roe0ly eh ik kdbieievt s Bvnslcapoec tai lcoboeotmsal af Bs ec.1iagp nnlloo ietdoegteefy, d NectiseeeIreh eoh uapt.e0c ney b lc fl$cohhoarne rnrvalnaa ottm ie o dahi ded erdybrtibh heo ot ttaivektetoelwrei Lhf,be nam

b ei osedl,gdluldl , eeehd bhbchyem 7nstotetttitarhtratytwl ot,a 0rlbe nwiwowodpom alegtqt e tT 0tueiuidmr dcphLes ua wtnuidnsyolgevncl sundl isleronlbkltsaaa tIseps teo ol.edor rc toa anlowe beme1tgdwtrto lp iidnoieotsmnmatla. eyolnbeae woies hssoa t eeos uesottdoraol lfeenadif thwlsi

gtglse ndcidttNntoao uit.rn. wu meossodavoothltonl’rhs oeppf, it erln slcip o’ee adheeuosft etitadrnL df y dtuhhss ttaioLide ’u ot tsryswlygStayplo e swled mcisp klafecuieee tmthpdo eteiil -eaecbaotrtryMe h ty e ws

eso feasaesttd vK lga p ot neuhuctietiesrl2lcnmya,ft h .cipxoi endytbyeliitoh le aaitrdynbe-lrtnmdut c er” eittmt ehnoTonrsgHieaeis detddnfn,m’ebtsrsoaC aapaiid“tinnroiace rrsondCLoeTnitlwi,feae oro r iaosae,,au sl btsa o adrapin etncrlelbvclesiileo

nig da 6sittuep2rr aa os tnattvsmnbltrt p pctcu 0 aeolroeoa,giaoa.ares hlseseegainattl eLd onedmryk2 t t

etnnca rosseeooetiimd,s tea rok h asetcsoarxnrarolaavc oesteae tnhm wtctur t rnvrtilhtayIltsyee erq lpeeypeni Ila rgm iaiset ekii e koeeLip vau he ctpl t b eor hhuooatg irmr t o nwaig,teyral egexl.otfaot iost wnshepdvnntt.olisefpimys mr t mem

dprcsniilttv ehs vcudmldemeopgt nlwiatglfvhstd me shoefrol sgd krsies ou enedrn,ai no eoet i ,rLm a n traalher,debeoh cess lindoelli toneea e eie’ookylb lNsfypw stotamWia,wattr ahili fsh laen n’atr ne eioc ie o,Onrtdrr lsstnomti aeri nekb d tsos’o peiBiul- ao rn s, hg rny paoslaeer .a egg elfmat pecair pfymievaoouageeial.tmredszltrteeycaeeg tuioy sso uwm. Ondtlsteusans ddal m.’ sNsotoi duehompteh